Retrospective Study
Copyright ©The Author(s) 2024.
World J Gastroenterol. Jan 14, 2024; 30(2): 158-169
Published online Jan 14, 2024. doi: 10.3748/wjg.v30.i2.158
Table 1 Patient population characteristics according to tumor budding
Characteristics
Total, n = 547Bd 1, n = 386Bd 2-3, n = 161P value
Sex0.514
Male317 (58.0)224 (58.0)93 (57.8)
Female230 (42.0)162 (42.0)68 (42.2)
Age in yr0.141
< 60276 (50.5)201 (52.1)75 (46.6)
≥ 60271 (49.5)185 (47.9)86 (53.4)
Chemotherapy0.055
Yes319 (58.3)234 (60.6)85 (52.8)
No228 (41.7)152 (39.4)76 (47.2)
Radiotherapy0.119
Yes32 (5.9)26 (6.7)6 (3.7)
No515 (94.1)360 (93.3)155 (96.3)
Perineural invasion< 0.001
Yes171 (31.3)100 (25.9)71 (44.1)
No376 (68.7)286 (74.1)90 (55.9)
Vascular invasion0.004
Yes152 (27.8)94 (24.4)58 (36.0)
No395 (72.2)292 (75.6)103 (64.0)
Clinical stages0.006
3436 (79.7)319 (82.6)117 (72.7)
4111 (20.3)67 (17.4)44 (27.3)
Lymphatic invasion0.019
N0134 (24.5)105 (27.2)29 (18.0)
N1258 (47.2)183 (47.4)75 (46.6)
N2155 (28.3)98 (25.4)57 (35.4)
Tumor location0.458
Right-sided colon167 (30.5)124 (32.1)43 (26.7)
Left-sided colon136 (24.9)93 (24.1)43 (26.7)
Rectosigmoid244 (44.6)169 (43.8)75 (46.6)